Cat /

Breed profile · FDA CVM July 2026 extract

Himalayan adverse-event record

Adverse-event filings for Himalayan (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.

Verify with FDA CVM →
#126 of 510
by report volume (all breeds)
640
FDA CVM reports on file
10.6%
death-coded share of reports
#44 of 275
by death-coded share (≥50 reports)

How the 640 reports break down

By recorded gender -- every report on file for Himalayan, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 48 36 24 12 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Himalayan drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Himalayan ranks #126 of 510 by total reports (640) and #44 of 275 by death-coded share (10.6%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#126
This breed, reports of 510
#44
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Himalayan has 640 reports now versus 631 in that prior snapshot: 9 more (1.4%).

Report change
+9
Death-coded reports
+0
Death-coded share
−0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Himalayan changes

Total Reports

640

High report volume

Deaths Reported

68

of 640 reports

Death-coded share of reports

10.6%

High death-coded share

Avg Age at Report

8.6 yr

4.2 kg avg weight

Breed Safety Scorecard

F (22/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
10.6%

Share of reports coded as a fatality

Euthanasia rate F
4.7%

Share of reports resulting in euthanasia

Full recovery rate C-
28.9%

Share of reports coded "Recovered/Normal"

5-year trend F
+30%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Himalayan death-coded reports 10.6%
Cross-breed median

10.6% of 640 himalayan reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Himalayan's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

11% 84th percentile Higher share than 84% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). Below this entry. 20%–25%: 2 indexed breeds (1%). Below this entry. 25%–30%: 3 indexed breeds (1%). Below this entry. 30%–35%: 4 indexed breeds (1%). Below this entry. 35%–40%: 5 indexed breeds (2%). Below this entry. 40%–45%: 6 indexed breeds (2%). Below this entry. 45%–50%: 3 indexed breeds (1%). Below this entry. 50%–55%: 7 indexed breeds (3%). Below this entry. 55%–60%: 7 indexed breeds (3%). Below this entry. 60%–65%: 21 indexed breeds (8%). Below this entry. 65%–70%: 11 indexed breeds (4%). Below this entry. 70%–75%: 15 indexed breeds (5%). Below this entry. 75%–80%: 13 indexed breeds (5%). Below this entry. 80%–85%: 11 indexed breeds (4%). Below this entry. 85%–90%: 12 indexed breeds (4%). Below this entry. 90%–95%: 12 indexed breeds (4%). Below this entry. 95%–100%: 142 indexed breeds (52%). This entry sits in this band. Himalayan 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 4.2 kg (9.3 lbs)

Top Reported Reactions

Vomiting 94
Lethargy (see also Central nervous system depression in 'Neurological') 72
Lack of efficacy (ectoparasite) - flea 69
Anorexia 55
Diarrhoea 44
Emesis 44
Weight loss 40
Behavioural disorder NOS 30

Most Referenced Drugs

Spinosad 98
Selamectin 77
Nitenpyram 58
Fluralaner Spot-On Solution 47
Imidacloprid + Moxidectin 42
Cefovecin 33
Frunevetmab 31
Selamectin;Sarolaner 23

Outcome Breakdown

Recovered/Normal
185 (32.3%)
Outcome Unknown
156 (27.2%)
Ongoing
154 (26.9%)
Died
38 (6.6%)
Euthanized
30 (5.2%)
Recovered with Sequela
10 (1.7%)

Gender Distribution

Male 314 (49.1%)
Female 312 (48.8%)
Unknown 12 (1.9%)
Mixed 2 (0.3%)

Reports by Year

Year Reports Trend
2010 49
2011 27
2012 40
2013 74
2014 51
2015 42
2016 44
2017 46
2018 33
2019 34
2020 19
2021 27
2022 25
2023 48
2024 39
2025 35
2026 7

Himalayan: high death-coded share in the FDA CVM extract

Signature read: Himalayan's 10.6% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Himalayan sits at #126 of 510 by report volume among all breeds and #12 of 55 among cat breeds, with 640 reports and 68 (10.6%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #44 of 275. Mean age at report: 8.6 years, average weight 4.2 kg (9.3 lbs).

Top reported signs: Vomiting (94), Lethargy (see also Central nervous system depression in 'Neurological') (72), Lack of efficacy (ectoparasite) - flea (69). Most-referenced drug: Spinosad (98 reports), followed by Selamectin (77) and Nitenpyram (58).

Outcome coding on 573 status-recorded reports is dominated by Recovered/Normal (32.3%). Annual submissions ranged 7-2,026 across 17 years on file.

Cat Breeds With a Similar Report Volume

Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.

Russian
611 reports · 7.2% death-coded
Bengal
673 reports · 4.6% death-coded
Crossbred Feline/cat
571 reports · 6.3% death-coded
American Shorthair
442 reports · 7.5% death-coded
Mixed (Cat)
298 reports · 10.7% death-coded
Manx
284 reports · 11.3% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Himalayan drawn from openFDA outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (10.6% death-coded here).

Mustang 10.4% · Horse Morgan 10.3% · Horse Appaloosa 10.2% · Horse Quarter Horse 11.1% · Horse

Similar average weight

Nearest other-species breeds by reported average weight (4.2 kg here).

Terrier - Yorkshire 4.2 kg · Dog New Zealand White 4.3 kg · Rabbit Flemish Giant 4.1 kg · Rabbit Turkey (other) 4.0 kg · Turkey

What to do with this cat

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Himalayan? ▼
There are 640 adverse event reports involving Himalayan in the FDA database, of which 68 were death-coded (10.6% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Himalayan ranks #126 of 510 by report volume among all breeds PlainBreed indexes (#12 of 55 among cat breeds).
Where does Himalayan sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Himalayan is #126 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #12 of 55. Among breeds with at least 50 reports, its death-coded share ranks #44 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Himalayan? ▼
The most commonly reported adverse reactions for Himalayan are Vomiting (94 reports), Lethargy (see also Central nervous system depression in 'Neurological') (72 reports), Lack of efficacy (ectoparasite) - flea (69 reports), Anorexia (55 reports), Diarrhoea (44 reports).
What drugs are most frequently associated with Himalayan adverse events? ▼
The drugs most frequently referenced in Himalayan adverse event reports are Spinosad (98 reports), Selamectin (77 reports), Nitenpyram (58 reports), Fluralaner Spot-On Solution (47 reports), Imidacloprid + Moxidectin (42 reports).
What is the average age of Himalayan in adverse event reports? ▼
The average age of Himalayan at the time of adverse event reports is 8.6 years, with an average weight of 4.2 kg (9.3 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Himalayan (Cat), extract as of July 2026 extract. 640 reports · 68 death-coded (10.6% of reports, not a mortality rate) · #126 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →